DSM completes acquisition of Erber Group
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces the completion of its acquisition of Erber Group for an enterprise value of €980 million.
The transaction – which excludes two smaller units in the Erber Group – is expected to be earnings enhancing in the first year upon completion. The acquisition of Erber Group was first announced on 12 June 2020.
DSM acquired Erber Group’s Biomin and Romer Labs. Erber Group’s specialty animal nutrition and health business Biomin specializes primarily in mycotoxin risk management and gut health performance management, whereas the Romer Labs business focuses on food and feed safety diagnostic solutions. Both expand DSM’s range of higher value-add specialty solutions.
The acquisition of Erber Group’s Biomin further strengthens DSM’s expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency, and better use of water and land. It is therefore very much aligned with DSM’s focus to make animal farming more sustainable from both an ecological and economical perspective. Romer Labs also complements DSM’s human nutrition and health offering to customers in the food & beverages market segments.
DSM – Bright Science. Brighter Living.™
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
For additional information on the news that is the subject of this release, contact firstname.lastname@example.org
At BIOMIN we harness the power of science to support animal health and performance. By applying state-of-the-art and proprietary technology we deliver natural, sustainable and profitable solutions to the livestock industry. For over 30 years we have pioneered innovative solutions for mycotoxin risk management and gut performance. Naturally Ahead.
Our in-house R&D program at the BIOMIN Research Center is staffed by over 100 scientific researchers and supported by eight Centers for Applied Animal Nutrition and a research network of 200 academic and research institutions globally. Our clients in the poultry, swine, ruminant and aquaculture sectors are located in more than 120 countries worldwide. BIOMIN is a part of ERBER Group.